Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXD1YI
|
||||
Drug Name |
5-Butyl-9-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene
|
||||
Synonyms |
CHEMBL322108
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C24H29NO2
|
||||
Canonical SMILES |
CCCCC1Oc2ccc(OC)cc2c3ccc4NC(C)(C)C=C(C)c4c13
|
||||
InChI |
InChI=1S/C24H29NO2/c1-6-7-8-21-23-17(18-13-16(26-5)9-12-20(18)27-21)10-11-19-22(23)15(2)14-24(3,4)25-19/h9-14,21,25H,6-8H2,1-5H3
|
||||
InChIKey |
NBYXOMZEWLMKJB-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | [1587926] | ||
mRNA of androgen receptor | Target Info | [1587926] | |||
Pathway Interaction Database | Cellular roles of Anthrax toxinsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.